/Factset%20Research%20Systems%20Inc_%20logo%20on%20website%20by-monticello%20via%20Shutterstock.jpg)
FactSet Research Systems, Inc. (FDS) provides financial technology and enterprise solutions designed for the investment industry. Valued at a market cap of $17.7 billion, the company offers workstations, portfolio analytics, and enterprise data services, along with managed solutions for data, performance, risk, and reporting, providing subscription-based financial data, and market intelligence through customizable platforms, data feeds, and cloud-based tools. FDS is expected to announce its fiscal Q2 2025 on Thursday, Mar. 20.
Ahead of the event, analysts expect the Norwalk, Connecticut-based company to report a profit of $4.20 per share, down marginally from $4.22 per share in the year-ago quarter. However, the company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
For fiscal 2025, analysts expect FDS to report EPS of $17.21, up 4.6% from $16.45 in fiscal 2024. In addition, its EPS is expected to rise 8.5% year-over-year to $18.68 in fiscal 2026.
FDS stock has underperformed the S&P 500’s ($SPX) 22.6% gains over the past 52 weeks, with shares down 1.7% during this period. Moreover, it has also lagged behind the Financial Select Sector SPDR Fund’s (XLF) 32.3% gains over the same time frame.
On Dec. 19, FDS shares closed up more than 3% after reporting higher quarterly profits, driven by a 4.9% increase in annual subscription value (ASV) to $2.27 billion, reflecting strong demand for its financial data services. The company posted Q1 adjusted earnings of $4.37 per share and revenue of $568.7 million, surpassing expectations. Investor optimism was further fueled by its positive outlook on a strong sales pipeline and innovative product offerings.
Analysts’ consensus opinion on FDS stock is cautious, with a “Hold” rating overall. Out of 18 analysts covering the stock, one advises a “Strong Buy” rating, 11 give a “Hold,” and six recommend “Strong Sell.”
As of writing, FDS is trading below the average analyst price target of $473.36.
